Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q2 2019 · 10-Q
Revenue$16.85M$16.85M+36.5% vs Q2 2018 Net Income$1.23M$1.23M−61.4% vs Q2 2018 EPS Diluted$0.01$0.01−66.7% vs Q2 2018 Gross Profit$11,951,000+31.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,696,000−27.4% Free Cash Flowderived$2,246,000−38.7% Margins · derivedGross margin70.9%−2.5 pt vs Q2 2018
Operating margin7.4%−19.3 pt vs Q2 2018
Net margin7.3%−18.5 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 7, 2019 · 38 d after period end